Patents by Inventor Katherine Stemke-Hale

Katherine Stemke-Hale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of
    Patent number: 8435533
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: May 7, 2013
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of
    Patent number: 8298542
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: October 30, 2012
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
    Patent number: 8206724
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: June 26, 2012
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia
    Publication number: 20100316662
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Application
    Filed: August 2, 2010
    Publication date: December 16, 2010
    Applicant: AUBURN UNIVERSITY
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of
    Patent number: 7811592
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: October 12, 2010
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chilamydia
    Publication number: 20080025998
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Application
    Filed: April 19, 2007
    Publication date: January 31, 2008
    Inventors: Stephen Johnston, Katherine Stemke-Hale, Kathryn Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
    Publication number: 20070149474
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Application
    Filed: December 27, 2006
    Publication date: June 28, 2007
    Inventors: Stephen Johnston, Katherine Stemke-Hale, Kathryn Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia psittaci
    Publication number: 20030185848
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening the Chlamydia psittaci genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses in bovines or other non-human animals. The ability of an antigen to produce an immune response may be employed in vaccination of bovines or antibody preparation techniques.
    Type: Application
    Filed: December 15, 2000
    Publication date: October 2, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
    Publication number: 20020183272
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Application
    Filed: December 17, 2001
    Publication date: December 5, 2002
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck